NASDAQ:GENE
Genetic Technologies Ltd Stock News
$2.22
-0.137 (-5.81%)
At Close: May 02, 2024
GENE Stock Price Increases Over 80% Pre-Market: Why It Happened
09:12am, Thursday, 21'st Jan 2021
The stock price of Genetic Technologies Limited (NASDAQ: GENE) is trading at over 80% pre-market today. This is why it happened.
Genetic Technologies Provides Update on its COVID-19 Disease Severity Risk Test and Expansion into Germline Testing
07:00am, Thursday, 21'st Jan 2021
MELBOURNE, Australia, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”), provides the following update to the market
Genetic Technologies Interview Aired on Bloomberg International on the RedChip Money Report
04:30pm, Monday, 23'rd Nov 2020
MELBOURNE, Australia, Nov. 23, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce an interview with its
Genetic Technologies to Hold Investor Webinar and Q&A Session on November 19
08:30am, Tuesday, 17'th Nov 2020
MELBOURNE, Australia, Nov. 17, 2020 (GLOBE NEWSWIRE) -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE, “Company”) is pleased to announce its interim-CEO, Dr.
Genetic Technologies Announces Closing of $5.1 Million Registered Direct Offering
12:30am, Tuesday, 21'st Jul 2020
MELBOURNE, Australia, July 20, 2020 -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests,.
Genetic Technologies Announces $5.1 Million Registered Direct Offering
12:02pm, Thursday, 16'th Jul 2020
MELBOURNE, Australia, July 16, 2020 -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests,.
Genetic Technologies Provides Update on COVID-19 Disease Severity Test
12:00pm, Wednesday, 15'th Jul 2020
Highlights Genetic Technologies has filed a provisional patent for its COVID-19 Severity Risk Test with the Patent Office in AustraliaThe COVID-19 Severity Risk Test.
Genetic Technologies CEO to Participate in Investor Webinar and Q&A Session on June 24, 2020
12:00pm, Tuesday, 23'rd Jun 2020
MELBOURNE, Australia, June 23, 2020 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”) is pleased to announce that its.
US Patent Office Grants Key Risk Test Patent
12:00pm, Thursday, 18'th Jun 2020
Issuance of US Patent No: US 10,683,549, Methods for assessing risk of developing breast cancer.Filed provisional patent for its COVID-19 Severity Risk Test, 2020901739 –.
Insider Buying: The Genetic Technologies Limited (ASX:GTG) Independent Non-Executive Chairman Just Bought 24% More Shares
08:49pm, Thursday, 04'th Jun 2020
Potential Genetic Technologies Limited (ASX:GTG) shareholders may wish to note that the Independent Non-Executive...
Genetic Technologies Announces Closing of $8.0 Million Public Offering
01:00am, Friday, 29'th May 2020
Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) (the “Company”), a leader in the development of genetic risk assessment tests, today announced the closing of its previously announced public
